These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1402675)

  • 21. [Status of T- and B-lymphocytes in long living CBA--F1 (CBA X C57BL/6) chimeras].
    Cherniakhovskaia IIu; Nesterenko VG; Filitis LN; Fontalin LN; Novikova TK
    Biull Eksp Biol Med; 1978 Aug; 86(8):197-200. PubMed ID: 28802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and characterization of the antigen presenting cell in rat autoimmune myocarditis: evidence of bone marrow derivation and non-requirement for MHC class I compatibility with pathogenic T cells.
    Ratcliffe NR; Wegmann KW; Zhao RW; Hickey WF
    J Autoimmun; 2000 Nov; 15(3):369-79. PubMed ID: 11040077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells.
    Doe B; Selby M; Barnett S; Baenziger J; Walker CM
    Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8578-83. PubMed ID: 8710913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo.
    Paglia P; Chiodoni C; Rodolfo M; Colombo MP
    J Exp Med; 1996 Jan; 183(1):317-22. PubMed ID: 8551239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lethal graft-vs-host disease across major histocompatibility barriers: requirement for leucyl-leucine methyl ester sensitive cytotoxic T cells.
    Thiele DL; Charley MR; Calomeni JA; Lipsky PE
    J Immunol; 1987 Jan; 138(1):51-7. PubMed ID: 2946780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice.
    Serreze DV; Gaskins HR; Leiter EH
    J Immunol; 1993 Mar; 150(6):2534-43. PubMed ID: 8450229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antigen-presenting T cells. I. Class I alloantigen (bm1)-bearing T lymphoblasts efficiently stimulate a primary clonal response of Lyt-2+ cytotoxic lymphocyte precursors of B6 origin.
    Reimann J; Bellan A; Kabelitz D
    J Immunol; 1987 Feb; 138(4):1042-50. PubMed ID: 3492539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Features of T cells causing H-2-restricted lethal graft-vs.-host disease across minor histocompatibility barriers.
    Korngold R; Sprent J
    J Exp Med; 1982 Mar; 155(3):872-83. PubMed ID: 6977610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rat stem cells developing in irradiated SCID mice fail to become tolerized and cause lethal graft-versus-host disease.
    Surh CD; Kosaka H; Sprent J
    Am J Pathol; 1997 Aug; 151(2):591-9. PubMed ID: 9250172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM; Waller EK
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antigen-presenting cells for Lyt-2+ cells. I. Stimulation of unprimed Lyt-2+ cells by H-2 different Thy-1-Ia- cells prepared from spleen and bone marrow.
    Sprent J; Schaefer M
    J Immunol; 1988 Jun; 140(11):3745-50. PubMed ID: 2897393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
    Tomita Y; Mayumi H; Eto M; Nomoto K
    J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Features of cells controlling H-2-restricted presentation of antigen to T helper cells in vivo.
    Sprent J
    J Immunol; 1980 Nov; 125(5):2089-96. PubMed ID: 6968772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The epithelial cell-specific integrin, CD103 (alpha E integrin), defines a novel subset of alloreactive CD8+ CTL.
    Hadley GA; Bartlett ST; Via CS; Rostapshova EA; Moainie S
    J Immunol; 1997 Oct; 159(8):3748-56. PubMed ID: 9378961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response.
    Nahill SR; Welsh RM
    J Exp Med; 1993 Feb; 177(2):317-27. PubMed ID: 8093891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Requirement for recognition of class II molecules and processed tumor antigen for optimal generation of syngeneic tumor-specific class I-restricted CTL.
    Kern DE; Klarnet JP; Jensen MC; Greenberg PD
    J Immunol; 1986 Jun; 136(11):4303-10. PubMed ID: 2422280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thymus: a direct target tissue in graft-versus-host reaction after allogeneic bone marrow transplantation that results in abrogation of induction of self-tolerance.
    Fukushi N; Arase H; Wang B; Ogasawara K; Gotohda T; Good RA; Onoé K
    Proc Natl Acad Sci U S A; 1990 Aug; 87(16):6301-5. PubMed ID: 2117278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between CD8 dependency and determinant density using peptide-induced, Ld-restricted cytotoxic T lymphocytes.
    Alexander MA; Damico CA; Wieties KM; Hansen TH; Connolly JM
    J Exp Med; 1991 Apr; 173(4):849-58. PubMed ID: 1901079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytotoxic T lymphocyte precursor cells specific for the major histocompatibility complex class I-like antigen, Qa-2, require CD4+ T cells to become primed in vivo and to differentiate into effector cells in vitro.
    Muraoka S
    Eur J Immunol; 1991 Sep; 21(9):2095-103. PubMed ID: 1679712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxic T lymphocyte responses in allogeneic radiation bone marrow chimeras. The chimeric host strictly dictates the self-repertoire of Ia-restricted T cells but not H-2K/D-restricted T cells.
    Bradley SM; Kruisbeek AM; Singer A
    J Exp Med; 1982 Dec; 156(6):1650-64. PubMed ID: 6217271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.